SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filings

Filing date Form Description Filing Group View
NO ACT

NO ACT

Other
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
View HTML

Data provided by Kaleidoscope.